UCSF School of Medicine

The UCSF School of Medicine strives to advance human health through a fourfold mission of education, research, patient care and public service.

https://www.ucsf.edu/

 

Insights from ESMO Breast 2024 Annual Meeting
H

ESMO Breast 2024 Insights: "TROPION-Breast01 Additional Safety Analysis - Dato-DXd vs. Chemo in Pretreated, Inoperable/Metastatic HR+/HER2- BC"

By Insights from ESMO Breast 2024 Annual Meeting FEATURING Hope Rugo
By Insights from ESMO Breast 2024 Annual Meeting FEATURING Hope Rugo
350 views
May 20, 2024
Comments 0
Login to view comments. Click here to Login
Oncology & Hematology
12:19

New

A Guide for Shared Decision Making in Sickle Cell Disease

UCSF School of Medicine

M. Treadwell

13 views
08:49

ESMO 2024 Insights: Treatment Rechallenge After Grade 1 Trastuzumab-…

2024 ESMO Annual Meeting Insights Hub

K. Natsuhara

735 views
26:22

Best of ASCO® 2024: Myeloma Highlights and Practice Impacts

UCSF School of Medicine

A. Chari

170 views
25:09

Integrative Medicine Approaches for Patients With Primary CNS Tumors

UCSF School of Medicine

N. Butowski

133 views
09:34

ASCO® 2024 Insights: "Impact of ctDNA Surveillance on Clinical Care …

2024 ASCO® Annual Meeting Insights Hub

M. Lipsyc-Sharf

299 views
09:40

Trastuzumab Deruxtecan Approval for Metastatic HER2+ Bladder Cancer

UCSF School of Medicine

V. Koshkin

262 views
36:18

Metastatic Breast Cancer Comprehensive Review: ESMO Breast 2024 Awar…

Insights from ESMO Breast 2024 Annual Meeting

H. Rugo

1.2K views
10:09

ESMO Breast 2024 Insights: "Pooled Analysis of T-DXd Retreatment Aft…

Insights from ESMO Breast 2024 Annual Meeting

H. Rugo

649 views
07:29

ESMO Breast 2024 Insights: "CAPItello-291 Trial PFS2 & TFSC Updates …

Insights from ESMO Breast 2024 Annual Meeting

H. Rugo

337 views
11:03

ESMO Breast 2024 Insights: "TROPION-Breast01 Additional Safety Analy…

Insights from ESMO Breast 2024 Annual Meeting

H. Rugo

350 views
30:03

Recent Advances in Advanced Urothelial Cancers: Time for a New Stand…

UCSF School of Medicine

T. Friedlander

330 views
04:18

SABCS 2023 Insights: "Comparison of NGS Results From the Cerebrospin…

Insights from 2023 SABCS

L. Huppert

261 views
05:48

SABCS 2023 Insights: "Sequential Use of ADCs T-DXd & SG in Patients …

Insights from 2023 SABCS

L. Huppert

212 views
11:05

ASH 2023 Insights: "Alliance A051301/BMT-CTN 1201 Study - Ibrutinib …

Insights from 2023 ASH Annual Meeting

C. Andreadis

41 views
09:46

SABCS 2023 Insights: "ELEVATE Study Evaluating Elacestrant in Variou…

Insights from 2023 SABCS

H. Rugo

142 views
14:15

SABCS 2023 Insights: "KEYLYNK-009 Study - Pembro + Olaparib vs. Pemb…

Insights from 2023 SABCS

H. Rugo

321 views
08:24

SABCS 2023 Insights: "PROs From the CAPItello-291 Trial Investigatin…

Insights from 2023 SABCS

H. Rugo

606 views
19:22

SOHO 2023: BCMA/GPRC5D/FcRH5 - CARs/BsAbs - How to Choose in R/R MM

SOHO 2023 Eleventh Annual Meeting

A. Chari

150 views
22:17

IMS 2023 Insights: "Unraveling the Myeloma Proteome"

Insights from 2023 IMS Annual Meeting

A. Wiita

25 views
07:52

Independent Biomarkers Predictive of Outcomes With Enfortumab Vedoti…

ASCO GU 2023 Conference Coverage

T. Jindal

98 views
13:15

ASCO® 2023 Insights: "Biomarkers Predicting Response to 5 IO Arms in…

Insights from 2023 ASCO® Annual Meeting

D. Wolf

104 views
09:18

ASCO® 2023 Insights: "Enfortumab Vedotin +/- Pembro in Pts Who Are C…

Insights from 2023 ASCO® Annual Meeting

T. Friedlander

235 views
07:49

ESMO Breast Cancer 2023 KEYNOTE-355 Trial: Outcomes in TNBC Patients…

ESMO Breast Cancer 2023 Congress Coverage

H. Rugo

868 views
17:44

ESMO Breast Cancer 2023 Phase 3 DESTINY-Breast04 Trial Safety Analys…

ESMO Breast Cancer 2023 Congress Coverage

H. Rugo

51 views
09:05

AACR 2023 on KEYNOTE-966 Phase 3 Study: Pembro in Combination With G…

AACR 2023 Conference Coverage

K. Kelley

352 views
06:47

Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+ Sol…

UCSF School of Medicine

H. Kang

2.1K views
03:32

Management of Abemaciclib-Related Diarrhea in HR+/HER2- eBC

UCSF School of Medicine

S. Donahue

1.1K views
05:39

ASCO GU 2023 Analysis of the UNITE Study: Biomarkers of Response to …

ASCO GU 2023 Conference Coverage

T. Jindal

103 views
10:28

IO vs. Targeted Therapy as Adjuvant Treatment in BRAFm Advanced Mela…

UCSF School of Medicine

A. Daud

347 views
08:41

ASH 2022 Long-Term Outcomes of Patients With TDT Followed Up to 8 Ye…

ASH 2022 Conference Coverage

M. Walters

98 views
11:43

CARTITUDE-1: 2 Years Post-LPI Update on the Phase 1b/2 Study of Cilt…

UCSF School of Medicine

T. Martin

222 views
47

Lecture Summary - Impact of Primary Tumor Location on OS and PFS in …

UCSF School of Medicine

A. Venook

24 views
15:07

Impact of Primary Tumor Location on OS and PFS in Patients with mCRC…

UCSF School of Medicine

A. Venook

302 views
15:00

Ongoing Clinical Trials and Future Directions in Advanced Urothelial…

UCSF School of Medicine

V. Koshkin

65 views
20:17

ESMO 2021 Updates on 1L Pembro + Chemo vs. Placebo + Chemo for mTNBC…

UCSF School of Medicine

H. Rugo

124 views
09:20

ESMO 2021 Post Hoc Analyses from PALOMA-2 and PALOMA-3: Effect of Pa…

UCSF School of Medicine

H. Rugo

310 views
05:01

ctDNA-Guided Treatment Strategy: How to Apply in Clinical Practice?

UCSF School of Medicine

A. Venook

437 views
13:13

ASCO 2021 Updates on Lisinopril or Carvedilol in Prevention of Trast…

UCSF School of Medicine

P. Munster

577 views
04:37

ASCO 2021 Update: Comparing Cilta-Cel in CARTITUDE-1 vs. Real-World …

UCSF School of Medicine

T. Martin

135 views
11:08

ASCO 2021 Updates on EV-103: Durability Results and Long-Term Outcom…

UCSF School of Medicine

T. Friedlander

450 views
15:52

ASH 2020 IKEMA Trial Update on Isatuximab in R/R MM: Should We Consi…

UCSF School of Medicine

T. Martin

201 views